Director, Global Access Strategy & Pricing, Breast Cancer
Director, Global Access Strategy & Pricing, Breast Cancer
Employer Active
Job Alert
You will be updated with latest job alerts via email
Share
Job Alert
You will be updated with latest job alerts via email
$ 169700 - 282900
1 Vacancy
Job Description
The Global Access Strategy and Pricing (GASP) Breast Cancer Director role directly impacts the ability to achieve business objectives by supporting the development of strategic guidance on access pricing optimal reimbursement launch sequencing patient value and evidence generation for the Breast Cancer franchise.
The Breast Cancer franchise is one of the prioritized Oncology franchises and consists of products recently post DP3 with preDP3 indications and prelaunch and inline products. The franchise includes the following products: KAT6 CDK4 Vepdegestrant and Ibrance. The objectives for the franchise strategy is to advance the treatment of breast cancer through nextgeneration backbones of treatment and novel combinations from our internal portfolio and with external combination partners.
This position will function with a One Global Access and Value mindset and work in an aligned manner with the Breast GASP team and other GAV colleagues (USMA HV&E). The role will be most heavily focused on the early assets and indications for KAT6 and CDK4 and work closely with the CDK4 GASP Lead. This person will support the advancement of the integrated value and access strategy (IVAS) in partnership with the cross functional team and aligned to the brand strategy. The IVAS will optimize the long term value of the products by optimizing the pricing & access strategy including indication launch sequence and evidence generation plans. The position reports to the GASP Breast Cancer Team Lead within GAV.
ROLE RESPONSIBILITIES
- Lead generation of payer insights and support the translation into clear and cohesive integrated value and access pricing and evidence generation strategies for key markets to support the Breast Cancer Franchise.
- Provide subject matter expertise and support critical strategic discussions at Senior Leadership forums
- Support Global cross functional and local preparation of the EU JCA strategy in close partnership with HV&E
- Support shaping breast cancer lifecycle management and DP3 decision making by leveraging expertise in access and price strategies and scenario planning
- Deliver clear recommendations relating to payer strategy pricing and reimbursement analogue case studies evidence generation data collection and value proposition
- Participate in virtual cross functional teams including representing GAV at Commercial Subteams and at the GPT. Coordinate and lead projects related to specific asset threats and opportunities.
Generate & synthesize payer insights
- Maintain indepth understanding of payer regulations including novelnovel combinations fixed dose combinations and needs of all types of payers (e.g. HTA agencies institutions and patients) in key Pfizer markets.
- Knowledgeable about US Oncology Access & Pricing Landscape IDM Markets China Japan HTA/Payer requirements and EU JCA.
- Support assessment and communication of external access trends to anticipate potential challenges and opportunities for the Breast franchise
- Gather and synthesize feedback for development programs with health technology assessment agencies payers and relevant patient associations.
Develop payer value proposition and drive market access strategy
- Support the development of clear and cohesive access pricing and evidence generation strategy to optimize value of the Breast Franchise
- Lead discussions with Country Health & Value and Payer Channel Access Leads at critical junctures to ensure local insights are integrated into global plans that optimize longterm value for Breast Franchise
- Provide input into clinical development plans market access and pricing strategies and recommendations early HTA advice early economic models and evidence generation plans via the Integrated Value & Access Plan.
- Support alignment efforts with Commercial BAI Clinical Medical and Asset teams to ensure clinical trial design real world evidence plan and commercial strategies reflect payer insights and align with Bold Moves in order to maximize value of the Breast Franchise.
- Support discussions and early buyin discussions with senior leadership on price and market access strategy and recommendations to support key business decision points
- Support development of the IVAS value proposition and valuebased agreement strategy and buyin from crossfunctional stakeholders
- Develop pricing & market access product and country assessments and run country workshops
- Support analyses and recommendations in partnership with HV&E to influence clinical trial design recommendations (e.g. endpoints comparators PROs) development of early economic model and generation of supplemental evidence (e.g. comparativeeffectiveness studies leveraging realworld evidence) to strengthen our value proposition and pricing/access opportunity.
Advance functional excellence in Global Market Access
- Build and maintain relationships with crossfunctional teams including HEOR Medical Commercial BAI and others to drive payer perspective and optimize for reimburseability per critical business needs globally for breast cancer.
- Work efficiently and collaboratively in a highly matrixed environment.
- Develop expertise in US IDM China markets and launch requirements.
BASIC QUALIFICATIONS
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers develop and coach others oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
- Bachelors degree minimum required.
- 8 years of experience required with Bachelors; 7 years of experience required with Masters / MBA; 5 years of experience required with PharmD / PhD preferably in pharmaceutical industry or related consulting services sufficient to have developed an understanding of the global and US payer and market access environment.
- Experience in developing and executing Pricing & Market Access strategies and deliverables on US and key exUS markets such as Germany France UK Italy and/or Spain China Japan.
- Excellent oral and written English communication skills required
PREFERRED QUALIFICATIONS
- Advanced degree in a healthcare business or economic field preferred (PhD PharmD MPH MBA MS ...)
- Experience working in breast cancer agents globally and knowledge of HTA and Payer requirement is desirable. US IDM China country level HTA and negotiation experience is desirable.
- Strong knowledge and understanding of drug development process.
- Pharmaceutical business including experience in strategy development and interaction with customers.
- Strong project management abilities (contracting budgeting vendor management) essential.
- Demonstrated ability to manage multiple projects involving complex processes significant budget competing deadlines and rapidly shifting priorities.
- Excellent interpersonal skills required; ability to understand and respond to multiple internal and external customers and influence in a matrix environment.
- Skilled in functioning within a matrix organization where managing through influence is required and experience of managing people in a crosscultural environment.
Other Job Details:
- Last Date to Apply for Job: May 7th 2025.
- Position is hybrid and will require to work 2 to 3 days per week from site
- Ability to travel depending on business needs
Relocation assistance may be available based on business needs and/or eligibility.
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care providers name address and the type of payments or other value received generally for public disclosure. Subject to further legal review and statutory or regulatory clarification which Pfizer intends to pursue reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse your name address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race color religion sex sexual orientation age gender identity or gender expression national origin disability or veteran status. Pfizer also complies with all applicable national state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an EVerify employer. This position requires permanent work authorization in the United States.
Required Experience:
Exec
Employment Type
Full-Time
